Sequential Belimumab and T-cell Based Therapy in SLE
Clinical trial NCT04447053 · UNKNOWN
Trial details
- NCT number
- NCT04447053
- Sponsor
- National University Hospital, Singapore
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2025-05-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.